Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Clinical trial NCT06295549 · TERMINATED
Trial details
- NCT number
- NCT06295549
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-11
- Primary completion
- 2025-06-11
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.